Securities Registration: Employee Benefit Plan (s-8)
June 12 2017 - 4:55PM
Edgar (US Regulatory)
As
filed with the Securities and Exchange Commission on June 12, 2017
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
S-8
REGISTRATION
STATEMENT UNDER
THE
SECURITIES ACT OF 1933
ONCOSEC
MEDICAL INCORPORATED
(Exact
name of registrant as specified in its charter)
Nevada
|
|
98-0573252
|
(State
or other jurisdiction of
|
|
(I.R.S.
Employer
|
Incorporation
or organization)
|
|
Identification
No.)
|
5820
Nancy Ridge Drive
San
Diego, CA 92121
(Address
of principal executive offices, including zip code)
OncoSec
Medical Incorporated 2011 Stock Incentive Plan
(Full
title of the plan)
Punit
Dhillon
President and Chief Executive Officer
OncoSec Medical Incorporated
5820 Nancy Ridge Drive
San
Diego, CA 92121
(855)
662-6732
(Name,
address, and telephone number, including area code, of agent for service)
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer [ ]
|
Accelerated
filer [ ]
|
Non-accelerated
filer [ ] (Do not check if a smaller reporting company)
|
Smaller
reporting company [X]
|
|
Emerging
growth company [ ]
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act
. [ ]
CALCULATION
OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Title of Securities to be Registered
|
|
Amount to
be registered (1)
|
|
Proposed maximum
offering price
per share (2)
|
|
Proposed maximum
aggregate offering
price (2)
|
|
Amount of
registration fee
|
|
Common
Stock, par value $0.0001 per share
|
|
1,000,000
|
|
$
|
1.095
|
|
$
|
1,095,000
|
|
$
|
126.91
|
|
(1)
|
Represents
additional shares of the common stock, par value $0.0001 per share (the “Common Stock”), of OncoSec Medical Incorporated
(the “Registrant”) authorized for issuance under the OncoSec Medical Incorporated 2011 Stock Incentive Plan, as
amended (the ”Plan”). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the
“Securities Act”), this registration statement on Form S-8 (this “Registration Statement”) shall
also cover any additional securities that may be offered or issued in connection with any stock dividend, stock split, recapitalization
or other similar transaction.
|
|
|
(2)
|
Estimated
solely for the purpose of calculating the registration fee. Pursuant to Rule 457(c) and Rule 457(h) under
the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price have been
determined on the basis of the average of the high and low prices of the registrant’s common stock reported on the Nasdaq
Capital Market on June 5, 2017.
|
EXPLANATORY
NOTE
This
Registration Statement registers (a) an additional 500,000 shares of the Registrant’s Common Stock that may be offered and
sold under the Plan pursuant to an amendment of the Plan approved by the Board of Directors of the Registrant on October 11, 2016
and approved by the Shareholders of the Registrant on December 6, 2016 and (b) an additional 500,000 shares of the Registrant’s
Common Stock that may be offered and sold under the Plan, pursuant to the January 3, 2017 automatic increase in authorized
shares provided in Section 3(a) of the Plan. This Registration Statement relates solely to the registration of additional
securities of the same class as other securities for which one or more other registration statements filed on this form relating
to the same employee benefit plan are effective. Pursuant to General Instruction E. to Form S-8, the contents of the Registrant’s
previously filed registration statements on Form S-8 relating to the Plan (File No. 333-176537, File No. 333-188726,
File No. 333-197678, File No. 333-202752 and File No. 333-209948), filed with the Securities and Exchange Commission
on August 29, 2011, May 21, 2013, July 28, 2014, March 13, 2015 and March 4, 2016, respectively, including
any amendments thereto or filings incorporated therein, are hereby incorporated by reference herein to the extent not otherwise
amended or superseded by the contents hereof.
Item
8. Exhibits.
Exhibit
Number
|
|
Document
|
|
|
|
4.1
|
|
OncoSec
Medical Incorporated 2011 Stock Incentive Plan, as amended
|
|
|
|
5.1
|
|
Opinion
of McDonald Carano LLP
|
|
|
|
23.1
|
|
Consent
of McDonald Carano LLP (contained in Exhibit 5.1)
|
|
|
|
23.2
|
|
Consent
of Mayer Hoffman McCann P.C.
|
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf
by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on June 12, 2017.
|
ONCOSEC
MEDICAL INCORPORATED
|
|
|
|
|
By:
|
/s/
Punit Dhillon
|
|
|
Punit
Dhillon
|
|
|
President
and Chief Executive Officer
|
Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
capacities and on the dates indicated.
SIGNATURE
|
|
TITLE
|
|
DATE
|
|
|
|
|
|
/s/
Punit Dhillon
|
|
President,
Chief Executive Officer and Director
|
|
June
12, 2017
|
Punit
Dhillon
|
|
(
Principal
Executive Officer
)
|
|
|
|
|
|
|
|
/s/
Richard Slansky
|
|
Chief
Financial Officer
|
|
June
12, 2017
|
Richard
Slansky
|
|
(
Principal
Financial and Accounting Officer
)
|
|
|
|
|
|
|
|
/s/
James DeMesa
|
|
Director
|
|
June
12, 2017
|
James
DeMesa
|
|
|
|
|
|
|
|
|
|
/s/
Avtar Dhillon
|
|
Director
|
|
June
12, 2017
|
Avtar
Dhillon
|
|
|
|
|
|
|
|
|
|
/s/
Anthony Maida
|
|
Director
|
|
June
12, 2017
|
Anthony
Maida
|
|
|
|
|
EXHIBIT INDEX
Exhibit
Number
|
|
Document
|
|
|
|
4.1
|
|
OncoSec
Medical Incorporated 2011 Stock Incentive Plan, as amended
|
|
|
|
5.1
|
|
Opinion
of McDonald Carano LLP
|
|
|
|
23.1
|
|
Consent
of McDonald Carano LLP (contained in Exhibit 5.1)
|
|
|
|
23.2
|
|
Consent
of Mayer Hoffman McCann P.C.
|
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From Mar 2024 to Apr 2024
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From Apr 2023 to Apr 2024